Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men
December 1998
in “Dermatologic Surgery”
TLDR Hair loss is more common in men aged 18-49 and increases with age.
This document contains summaries of various studies on the prevalence of male pattern hair loss (MPHL) in men aged 18-49. The studies found that MPHL is more prevalent than previously reported, with the degree of hair loss increasing with age. The studies used various classification systems to categorize the extent of hair loss. The results suggest that further research is needed to better understand the natural history of hair loss in untreated men.
View this study on journals.lww.com →
Cited in this study
research A hair growth questionnaire for use in the evaluation of therapeutic effects in men
The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.
research Classification scale for male and female androgenetic alopecia.
Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.
Related
research Impact of female pattern hair loss on the quality of life of patients
research Finasteride in The Treatment of Female Androgenic Alopecia
Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.
research Male pattern baldness: an update.
Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.
research Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
Finasteride is effective in growing hair and stopping hair loss in men with mild to moderate alopecia.
research Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men
Hair loss is more common in men aged 18-49 and increases with age.
research MALE PATTERN ALOPECIA
The document concludes that advancements in hair restoration surgery have led to more natural results and patient satisfaction, with hope for future improvements in treatment.